Charles P.
- Country
- Belgium
- Department
- Cardiology
Research Overview
- Evaluation of Colchicine Efficacy in Reducing Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease: A Randomized, Placebo-Controlled Trial
- A Phase 3, Randomized, Double-Blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome
Data & Insights
Has run more than one trial at 9 of 317 partner sites.
Specializations
Cardiovascular Interventions
The investigator specializes in treating patients with coronary artery disease, particularly focusing on outcomes following percutaneous coronary intervention. Their research encompasses innovative therapeutic approaches for post-intervention cardiac care.
- Post-PCI Treatment Optimization
- Coronary Revascularization
- Preventive Cardiology
Their work extends to evaluating interventional strategies for reducing adverse cardiac events.
Acute Cardiac Care
The investigator focuses on managing acute coronary syndrome and developing treatment strategies for patients recovering from heart attacks. Their expertise includes evaluation of novel therapeutic agents for cardiovascular event prevention.
- Post-Myocardial Infarction Care
- Cardiovascular Risk Management
- Secondary Prevention Strategies
Their research addresses comprehensive care approaches for acute cardiac conditions.
Cardiovascular Outcomes
The investigator studies major adverse cardiovascular events and their prevention, with particular attention to cardiovascular mortality and stroke prevention in cardiac patients.
- Composite Cardiovascular Endpoints
- Long-term Cardiac Outcomes
- Risk Reduction Strategies
Their research evaluates therapeutic interventions for improving cardiovascular outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.